Incyte
Bryn McCrossan-Maire is an experienced finance professional with a robust background in technical operations and cost accounting. Currently serving as Senior Director of Global Technical Operations Finance at Incyte since January 2023, Bryn has previously held several senior roles at Celgene from April 2010 to January 2023, including Senior Director and Director of Global Cost Accounting. Prior experience also includes positions as Manufacturing Controller at Gucci, Senior Industrial Financial Analyst and Industrial Financial Analyst at Baxter Pharmaceuticals, and Financial Analyst at SGI. Bryn's educational background includes studies at the Faculty of Economics and Business, University of Neuchâtel.
This person is not in any teams
This person is not in any offices
Incyte
22 followers
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.